'The Top Line': 2023's biopharma layoffs, plus this week's headlines

Layoffs have hit biopharma hard over the last year and a half. In this episode Fierce Biotech's Max Bayer and Gabrielle Mason will discuss the recent trends. We also cover a gene therapy by Sarepta Therapeutics, Abbott's new FDA approval, plus this week's headlines. 

To learn more about the topics in this episode: 

"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

 

To Listen to More Episodes from The Top Line